term survival was significantly decreased for patients diagnosed with either frailty alone or both frailty and sarcopenia who underwent both surgical (Fig, A) and nonsurgical management (Fig, B) . In multivariate regression models, frailty was the only independent variable (hazard ratio, 7.7; 95% confidence interval, 3.2-18.7; P < .001) that predicted mortality.
Comparison of Bovine Carotid Xenograft Versus Expanded Polytetrafluoroethylene Grafts for Forearm Loop Hemodialysis Access
Objective: Forearm loop grafts are a useful option for dialysis access in patients without suitable forearm veins. Bovine carotid artery (BCA) and expanded polytetrafluoroethylene (ePTFE) grafts are commonly used for this purpose, but no data exist to support the use of one over the other in the forearm loop conformation.
Methods: We performed a retrospective review of 57 forearm loop grafts implanted at two institutions with a shared patient population between January 2009 and May 2017. Primary and secondary patency rates were calculated by univariate analysis and a Cox regression model adjusted for age, sex, and body mass index.
Results: There were 26 BCA and 31 ePTFE grafts placed during the study period. Mean follow-up was 37 6 25 months. Primary and secondary patency rates in the BCA group were 71.7% and 83.6%, 54.8% and 71.1%, and 28.9% and 62.2% at 6, 12, and 24 months, respectively. In the ePTFE group, primary and secondary patency rates were 56. 8% and 66.7%, 39.3% and 59.7%, and 26.9% and 40.4% at 6, 12, and 24 months (Fig) . When adjusted for age, sex, and body mass index, secondary patency was significantly better with BCA compared with ePTFE (P ¼ .04). Infection rates were 7% (two grafts) for BCA and 3% (one graft) for ePTFE.
Conclusions: Bovine carotid xenografts in forearm loop configuration for hemodialysis access have improved secondary patency and similar infection rates compared with ePTFE forearm loops. Author Disclosures: B. Colvard: Nothing to disclose; K. Lavignia: Nothing to disclose; V. T. Ho: Nothing to disclose; N. Itoga: Nothing to disclose; A. Dua: Nothing to disclose; E. J. Harris: Nothing to disclose; M. Mell: Nothing to disclose; E. Sorial: Nothing to disclose; M. Garcia-Toca: Nothing to disclose.
Disease-Based Observation Cohort Study of Patients with Thoracoabdominal Aortic Aneurysm
Chulhi Kang, Matthew A. Bartek, Sherene Shalhub, Derek P. Nathan, Matthew P. Sweet. University of Washington, Seattle, Wash
Objective: Current understanding of thoracoabdominal aortic aneurysms (TAAAs) is limited to case series and administrative data describing patients selected to undergo surgical repair. Little is known about the overall cohort of patients with TAAA, specifically those not selected for repair. The purpose of this study was to describe a disease-based cohort of patients with TAAA.
Methods: An academic multihospital institutional database was screened by diagnosis codes for TAAA from 2009 to 2017 using the International Classification of Diseases, Ninth Revision and Tenth Revision. Diagnosis was then confirmed or rejected by chart review and the CT finding of aneurysmal degeneration >3.2 cm of the paravisceral aorta in continuity with aneurysmal aorta meeting standard criteria for repair. Patients younger than 18 years and those with mycotic aneurysm were excluded. Patients underwent four broad categories of repair: open; endovascular with branched grafts; hybrid, defined as visceral debranching followed by thoracic endovascular aortic repair; and incomplete repair, in which the paravisceral segment was intentionally left unaddressed. The primary outcome measure for those receiving an operation was a composite measure of "good" outcome, defined as survival at 1 year, return to preoperative functional status, and freedom from permanent loss of organ system function.
Results: There were 406 patients who met the inclusion criteria. Demographic data and composite good outcomes are reported in the Table. (47%) who were deemed ineligible for or declined treatment. Reintervention was common and occurred at a significantly higher rate in the hybrid group compared with other groups (rates for hybrid, endovascular, partial, and open were 46%, 28%, 26%, and 18%, respectively).
Conclusions: This inclusive cohort study shows that nearly half of patients with TAAA do not undergo repair despite access to all treatment options. This suggests that data from surgical case series are achieved in highly selected cohorts and do not reflect overall outcomes. Among those receiving intervention, similar outcomes are achieved with different techniques in appropriately selected patients. Survival benefit was realized during a 30-month period in all operative groups except in the hybrid group compared with nonoperative patients. Objective: The use of duplex ultrasound for surveillance after fenestrated endovascular aneurysm repair (FEVAR) is not well studied. Our objective was to further characterize normal and abnormal duplex ultrasound findings in renal branch grafts after FEVAR.
Methods: We retrospectively reviewed a single-center experience involving consecutive patients treated with the Zenith fenestrated endovascular graft (ZFEN) device (Cook Medical, Bloomington, Ind). Postoperative imaging with computed tomography (CT) angiography was obtained at usual intervals. As experience progressed, duplex ultrasound was obtained in a nonstandardized protocol, particularly in patients with reduced renal function. Loss of renal patency was defined as occlusion or stenosis >50%.
Results: A total of 116 patients were treated with FEVAR, of whom 60 (51.7%) had concurrent CT and renal duplex ultrasound images available for review. Six patients (10%) had limited ultrasound studies because of bowel gas and were excluded. This left a total of 94 renal stents placed in 54 patients with a mean follow-up of 23 months. Twelve cases of renal patency loss in 10 patients (9 stenoses, 3 occlusions) were found on CT, 11 (91.6%) of which had concurrent abnormalities found on ultrasound. Stents with compression at the fenestration junction exhibited elevated mean peak systolic velocities (PSVs) compared with nonstenosed stents (349.2 vs 115.3 cm/s; P ¼ .003). Stenosis in the most proximal portion of the stent (ie, within the main body) showed no difference in proximal PSVs (86.0 vs 131.9 cm/s; P ¼ .257) but showed significantly dampened PSVs in the mid (17.5 vs 109.9 cm/s; P ¼ .027) and distal (19.0 vs 78.3 cm/s; P ¼ .028) segments compared with nonstenosed stents. All occluded stents demonstrated no flow detection. Proximal PSV served as a strong classifier for junctional stenosis (area under the curve, 0.98; Fig) . A combined criterion of proximal PSV >215 cm/s or distal PSV <25 cm/s resulted in a sensitivity of 91.6% and specificity of 85.3% for detecting patency loss. All stents underwent successful reintervention. Seven of 10 (70%) patients had detectable >25% increase in serum creatinine concentration associated with renal patency loss.
Conclusions: Duplex ultrasound is a clinically useful modality for surveillance of renal branch grafts after FEVAR. Patterns of segmental velocity elevation (proximal PSV >215 cm/s) and dampening in the distal renal segment indicate potential hemodynamic compromise, and those patients should be considered for secondary intervention. Objective: Treatment of type B aortic dissections with thoracic endovascular aortic repair (TEVAR) has been adopted in many centers with the goal of covering the proximal entry tear. Coverage of the left subclavian artery is commonly required to achieve a dissection-free proximal seal zone. A novel thoracic single side-branched (TSSB) endograft offers a potential off-the-shelf option to achieve total endovascular incorporation of the left subclavian artery during zone 2 TEVAR. The aim of this study was to determine what percentage of patients with type B aortic dissection who require zone 2 TEVAR meet the anatomic requirements for this device.
Methods: All consecutive patients undergoing TEVAR for type B aortic dissections at a single institution from 2006 to 2016 were evaluated. Three-dimensional centerline reconstruction of preoperative computed tomography angiography was performed to identify the diameter of the aorta, distances between branch vessels, diameter of the target branch vessel, and location of the primary entry tear. Only patients who required zone 2 TEVAR were included in the analysis. The primary outcome was percentage of patients who met all anatomic requirements for the TSSB endograft. The specific requirements leading to nonsuitability were also calculated. 
